Key points from article :
A drug molecule known as DSP-1181 invented by artificial intelligence will go into human trials.
Will be used to treat patients who have obsessive-compulsive disorder (OCD) if successful.
The AI sifted through potential compounds, checking them against a huge database of parameters.
Took only 1 year compared to 5 years of typical drug development.
Created by Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
